Acusphere Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Acusphere, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of Imagify (perflubutane polymer microspheres) for injectible suspension. The companys Imagify acts as a cardiovascular drug for the detection of coronary artery disease by enabling ultrasound to accurately assess myocardial perfusion. It serves customers in the United States, Europe, and Asia. Acusphere, Inc. was founded in 1993 and is headquartered in Lexington, Massachusetts.
No news available
Limited Time
Get premium stock ratings, research, analyst insights, and portfolio tools with a limited-time discount.
25% off Seeking Alpha Premium through July 7.
Claim 25% discountSponsored partner offer: The 25% Seeking Alpha Premium discount is available for a limited time. Terms apply.